SCHEMBL24711784

SCHEMBL24711784

Cc1ccc(NC(=O)c2cc(NC(=O)Cc3ccccc3)ccc2N2CCOCC2)cc1Cl

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.73
▸ KDM4E B2RXH2 4/20 0.73
▸ MAPT P10636 6/20 0.64
▸ HTT P42858 5/20 0.62
▸ SMN1; SMN2 Q16637 4/20 0.62
▸ NPSR1 Q6W5P4 2/20 0.62
▸ HPGD P15428 2/20 0.62
▸ MITF O75030 1/20 0.62
▸ G6PD P11413 1/20 0.62
▸ ALOX12 P18054 1/20 0.62
▸ MC4R P32245 1/20 0.62
▸ TLR9 Q9NR96 1/20 0.62
▸ ITGA4 P13612 1/20 0.62
▸ RAB9A P51151 5/20 0.60
▸ CYP3A4 P08684 2/20 0.58
▸ CYP2C9 P11712 2/20 0.58
▸ CYP2C19 P33261 2/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ NPC1 O15118 4/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24711005 0.87 ALDH1A1 (0.74) ALDH1A1KDM4EMAPTHTTSMN1; SMN2
SCHEMBL24710979 0.80 KMT2A (0.72) ALDH1A1KDM4EMAPTHTTSMN1; SMN2
SCHEMBL12653717 0.73 ALDH1A1 (0.74) ALDH1A1KDM4EMAPTHTTSMN1; SMN2
SCHEMBL7156743 0.73 SMN1; SMN2 (1.00) ALDH1A1KDM4EMAPTHTTSMN1; SMN2
SCHEMBL29967258 0.73 NPY2R (0.75) ALDH1A1KDM4EMAPTHTTSMN1; SMN2
SCHEMBL15545383 0.73 MAPT (0.68) ALDH1A1MAPTHTTSMN1; SMN2NPSR1
SCHEMBL29967407 0.72 NPY2R (0.74) ALDH1A1MAPTHTTSMN1; SMN2NPSR1
SCHEMBL24629835 0.72 MAPT (0.67) ALDH1A1MAPTHTTSMN1; SMN2NPSR1
SCHEMBL13597049 0.71 ALDH1A1 (0.77) ALDH1A1MAPTHTTSMN1; SMN2NPSR1
SCHEMBL13602309 0.71 KMT2A (0.64) ALDH1A1KDM4EMAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220395500-A1 SMALL MOLECULE ACTIVATORS OF INTERFERON REGULATORY FACTOR 3 AND METHODS OF USE THEREOF NEURALEXO, INC. 2022-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220395500-A1 SMALL MOLECULE ACTIVATORS OF INTERFERON REGULATORY FACTOR 3 AND METHODS OF USE THEREOF IRF3, IRF2BP2, STAT1 ALDH1A1 4853/4885KDM4E 2942/4885MAPT 4038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback